NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Rain Industries Q4 2025 Revenue Up 17% YoY to ₹43.01B; Adjusted EBITDA Surges 47%
Rain Industries reported a robust Q4 2025 with revenue reaching ₹43.01 billion, a 17% increase compared to Q4 2024. Adjusted EBITDA saw a significant jump of 47% YoY to ₹5.76 billion, driven primarily by the Carbon segment's strong performance and improved realizations. The company achieved an adjusted PAT of ₹0.51 billion, recovering from a loss in the same period last year. With $340 million in liquidity and no major debt maturities until 2028, the company maintains a stable financial position despite headwinds in the Cement and Advanced Materials segments.
முக்கிய அம்சங்கள்
Revenue from operations grew 17% YoY to ₹43.01 billion in Q4 2025.Adjusted EBITDA increased 47% YoY to ₹5.76 billion with margins expanding to 13.4%.Carbon segment revenue rose to ₹33.05 billion, supported by strong calcination demand and currency tailwinds.Cement segment faced volume pressure, dropping 5% QoQ to 575k MT due to monsoon impacts.Liquidity remains strong at $340 million with net debt at $837 million as of December 2025.
👀 கவனிக்க வேண்டியவை
The significant turnaround in profitability and strong Carbon segment performance are positive indicators for the stock. Investors should monitor the recovery of the Cement segment and the impact of raw material competition from the Li-ion battery industry on the Carbon business.
Rain Industries FY25 Standalone Net Profit Falls 75.7% YoY to ₹94.46 Million
Rain Industries reported a significant decline in its standalone financial performance for the fiscal year ended December 31, 2025. Annual standalone net profit plummeted to ₹94.46 million from ₹389.45 million in the previous year, representing a 75.7% drop. Total standalone income also saw a sharp reduction, falling from ₹2,054.28 million in FY24 to ₹1,439.53 million in FY25. For the quarter ended December 31, 2025, standalone net profit was just ₹6.31 million compared to ₹161.33 million in the same quarter last year.
முக்கிய அம்சங்கள்
Standalone FY25 Net Profit fell 75.7% YoY to ₹94.46 million from ₹389.45 millionTotal Standalone Income for FY25 decreased to ₹1,439.53 million from ₹2,054.28 million in FY24Standalone EPS for the full year dropped significantly to ₹0.28 from ₹1.16 in the previous fiscalQ4 FY25 standalone net profit stood at ₹6.31 million, a massive decline from ₹161.33 million in Q4 FY24The company noted a ₹5.84 million impact due to the implementation of new Labour Codes in India
👀 கவனிக்க வேண்டியவை
The sharp decline in standalone profitability is a major concern, and investors should closely examine the consolidated results to understand global segment performance. Caution is advised as the standalone earnings per share has eroded significantly compared to the previous year.
Indian Terrain Returns to Profitability in Q3 FY26 with ₹2.5 Cr PAT After Six Quarters of Losses
Indian Terrain Fashions reported a significant turnaround in Q3 FY26, posting a PAT of ₹2.5 crore compared to a loss of ₹3.4 crore in the previous year. Revenue grew 4.7% YoY to ₹101.4 crore, driven by a surge in online sales and franchise-led channels. The company successfully expanded its EBITDA margin to 12.58% from 6.12% through cost control and store rationalization. This performance marks the end of a six-quarter loss streak, supported by improved working capital efficiency and festive demand.
முக்கிய அம்சங்கள்
Reported PAT of ₹2.5 crore, ending a streak of six consecutive quarters of losses.EBITDA margin doubled to 12.58% from 6.12% YoY, reflecting improved operational efficiency.Online channel revenue surged by ₹8.6 crore, aided by a shift to an outright model with Flipkart.Net Working Capital days improved to 225 days from 241 days in March 2025.Store network rationalized to 194 outlets to focus on higher-margin, scalable formats.
👀 கவனிக்க வேண்டியவை
Investors should view this turnaround positively as the company's 'Theory of Constraints' initiatives and store rationalization are yielding results. Monitor the sustainability of margins and the growth of the MBO and Online channels in upcoming quarters.
Bohra Industries Reports Zero Revenue and Net Loss of ₹60.31 Lakhs in Q3 FY26
Bohra Industries reported zero revenue from operations for the quarter ended December 31, 2025, continuing a trend of no operational income. The company posted a net loss of ₹60.31 lakhs for the quarter, which is a slight improvement from the ₹63.98 lakhs loss in the previous quarter but worse than the ₹43.45 lakhs loss in the same period last year. Total expenses for the quarter stood at ₹60.31 lakhs, primarily driven by depreciation of ₹33.14 lakhs and other expenses of ₹21.61 lakhs. For the nine-month period, the net loss widened to ₹193.60 lakhs compared to ₹169.95 lakhs in the previous year.
முக்கிய அம்சங்கள்
Revenue from operations remained at zero for the quarter and the nine-month period ended December 31, 2025.Net loss for Q3 FY26 stood at ₹60.31 lakhs compared to a loss of ₹43.45 lakhs in Q3 FY25.Total expenses for the nine-month period increased to ₹193.62 lakhs from ₹169.95 lakhs year-on-year.Depreciation and amortization expenses accounted for a significant portion of costs at ₹33.14 lakhs for the quarter.Earnings Per Share (EPS) remained negative at ₹(0.28) for the quarter.
👀 கவனிக்க வேண்டியவை
Investors should exercise extreme caution as the company has reported zero revenue, indicating a complete halt or absence of core business operations. The persistent losses and lack of top-line growth suggest significant fundamental risks and potential liquidity concerns.
Cerebra Integrated Technologies reported a disastrous Q3 FY26 with revenue plummeting 92% YoY to ₹81.52 Lakhs and net losses widening to ₹16.74 Crore. The statutory auditors have issued a 'Disclaimer of Conclusion,' citing severe lack of evidence for inventory devaluations and unconfirmed receivables. Major red flags include ₹141.25 Crore in trade receivables outstanding for over a year and ₹100.28 Crore in overdue overseas dues from a 2022 sale. The company's financial health appears critical with significant accounting irregularities flagged by auditors.
முக்கிய அம்சங்கள்
Revenue from operations collapsed by 92.4% YoY to ₹81.52 Lakhs from ₹1,073.72 Lakhs.Net loss for the quarter doubled to ₹16.74 Crore compared to a loss of ₹8.29 Crore in the same period last year.Auditors flagged that ₹141.25 Crore out of ₹142.49 Crore total trade receivables (99%) are outstanding for more than one year.A massive ₹100.28 Crore remains overdue for over two years from an overseas party regarding the sale of a former subsidiary.Statutory auditors issued a Disclaimer of Conclusion due to ad-hoc inventory devaluation of ₹9.76 Crore without supporting evidence.
👀 கவனிக்க வேண்டியவை
Investors should exercise extreme caution or consider exiting as the auditor's disclaimer and massive unprovided receivables indicate potential total capital erosion. The combination of collapsing revenue and severe accounting transparency issues makes the stock highly speculative and risky.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Indian Terrain Q3 FY26: Returns to Profitability with 115% EBITDA Growth to ₹12.76 Cr
Indian Terrain Fashions reported a significant turnaround in Q3 FY26, posting a PAT of ₹2.56 Cr compared to a net loss of ₹3.44 Cr in the same period last year. While revenue grew modestly by 4.66% YoY to ₹101.40 Cr, operational efficiencies led to a massive 115.04% surge in EBITDA. The company successfully expanded its EBITDA margin to 12.58% from 6.12% through better product mix and disciplined cost control. Management highlighted structural improvements in working capital and a strong order book for the upcoming Spring-Summer 2026 season.
முக்கிய அம்சங்கள்
Revenue from operations increased 4.66% YoY to ₹101.40 Cr, sustaining momentum from the previous quarter.EBITDA more than doubled to ₹12.76 Cr, with margins expanding significantly by 646 bps to 12.58%.Reported a PAT of ₹2.56 Cr, marking a sharp recovery from a net loss of ₹3.44 Cr in Q3 FY25.Working capital efficiency improved through TOC-led initiatives, resulting in reduced debtor days and better cash conversion.Management confirmed a strong SS-26 order book, providing healthy revenue visibility for the upcoming quarters.
👀 கவனிக்க வேண்டியவை
The company has successfully transitioned from losses to profitability, indicating that its turnaround strategy and cost-control measures are yielding results. Investors should monitor the sustainability of these expanded margins and the execution of the SS-26 order book in future quarters.
Indian Terrain Returns to Profitability in Q3 FY26 with PAT of ₹2.56 Cr
Indian Terrain Fashions reported a significant turnaround in Q3 FY26, posting a net profit of ₹2.56 crore compared to a net loss of ₹3.44 crore in the same period last year. Revenue from operations grew by 4.6% year-on-year to ₹101.40 crore, while the company successfully reduced total expenses from ₹101.65 crore to ₹97.54 crore. The nine-month performance also showed massive improvement, with losses narrowing to ₹4.01 crore from ₹40.48 crore in the previous year. A one-time exceptional charge of ₹0.58 crore was recorded due to new labor code provisions.
முக்கிய அம்சங்கள்
Net Profit of ₹2.56 crore in Q3 FY26 vs a Net Loss of ₹3.44 crore in Q3 FY25Revenue from operations increased to ₹101.40 crore from ₹96.88 crore YoYTotal expenses decreased to ₹97.54 crore, aided by lower finance costs of ₹4.69 croreNine-month net loss narrowed significantly to ₹4.01 crore from ₹40.48 crore YoYExceptional item of ₹0.58 crore recognized for provisions under the New Labour Codes
👀 கவனிக்க வேண்டியவை
The company has demonstrated a strong operational turnaround and a return to quarterly profitability. Investors should watch for sustained revenue growth and margin stability in the coming quarters to confirm a long-term recovery trend.
Indian Terrain Q3 Results: Turnaround to Net Profit of ₹2.56 Cr; Revenue Up 4.7% YoY
Indian Terrain Fashions Limited reported a significant turnaround in Q3 FY26, posting a net profit of ₹2.56 crore compared to a net loss of ₹3.44 crore in the same period last year. Revenue from operations grew by 4.7% YoY to ₹101.40 crore, while the company successfully reduced total expenses from ₹101.65 crore to ₹97.54 crore. The 9-month performance also showed drastic improvement, with the net loss narrowing to ₹4.01 crore from a loss of ₹40.48 crore in the previous year. A one-time exceptional charge of ₹0.58 crore was taken for new labor code provisions.
முக்கிய அம்சங்கள்
Revenue from operations rose to ₹101.40 crore in Q3 FY26 from ₹96.88 crore in Q3 FY25.Net Profit stood at ₹2.56 crore for the quarter, reversing a loss of ₹3.44 crore in the year-ago period.Finance costs were reduced to ₹4.69 crore from ₹5.47 crore YoY, contributing to improved margins.9-month net loss narrowed significantly to ₹4.01 crore compared to a loss of ₹40.48 crore in the previous year.Exceptional item of ₹0.58 crore recognized as a provision for the New Labour Codes (Code on Wages/Social Security).
👀 கவனிக்க வேண்டியவை
The company's return to profitability and significant reduction in 9-month losses indicate a successful operational turnaround. Investors should monitor if this margin improvement is sustainable over the next two quarters before considering long-term positions.
Rainbow Children's Medicare Q3 FY26: Revenue Up 12% to ₹445 Cr; New CEO Appointed
Rainbow Children's Medicare reported a 12% YoY revenue growth to ₹445.4 crores for Q3 FY26, while PAT grew 7% to ₹73.9 crores. The company is transitioning from a heavy expansion phase to an execution phase, having recently commissioned hospitals in Rajahmundry and Electronic City. Despite steady operational growth in deliveries (up 16%) and IP discharges (up 9%), occupancy remained at 47.2% due to muted seasonal illnesses. The appointment of Abrarali Dalal as CEO and a strong cash reserve of ₹579 crores position the company for future organic and inorganic growth.
முக்கிய அம்சங்கள்
Revenue grew 12% YoY to ₹445.4 crores; EBITDA increased 9% to ₹147 crores with a 33% margin.Deliveries saw an impressive 16% YoY growth, while IP discharges and OP volumes rose by 9% and 18% respectively.Maintains a robust balance sheet with ₹579 crores in cash to fund future CAPEX and M&A through internal accruals.Commissioned 100-bed Rajahmundry and 90-bed Electronic City units; 60-bed Hennur unit awaiting final approvals.Successful first pediatric liver transplant in Bengaluru hub, achieving a 94% survival rate across the network.
👀 கவனிக்க வேண்டியவை
Investors should monitor the ramp-up of new units and the impact of the new CEO on improving occupancy levels, which currently sit below 50%. The stock remains a solid long-term play on specialized pediatric healthcare given the strong cash position and execution focus.
Rain Industries Subsidiary Joins €1.7M German-Funded Battery Graphite R&D Program
Rain Carbon Germany, a wholly owned subsidiary of Rain Industries, has joined a three-year R&D program titled 'USE-G' to develop sustainable graphite extraction and coating technologies for the European battery industry. The project has a total budget of €1.70 million, with €1.14 million funded by the German Federal Ministry for Economic Affairs and Energy. Rain's specific role is to develop advanced carbon coating materials and sustainable processes to improve battery anode performance. This initiative aims to create a circular economy for lithium-ion batteries and reduce reliance on Chinese supply chains.
முக்கிய அம்சங்கள்
Three-year R&D program (USE-G) launched to run from January 2026 through December 2029.Total project budget of €1.70 million with €1.14 million in government funding support.Rain Carbon to develop sustainable carbon coating materials as alternatives to traditional coal tar.Partnership includes Northern Graphite, H.C. Starck Tungsten, and Friedrich Schiller University Jena.Focus on recovering graphite from battery black mass and using cleaner purification methods without hydrofluoric acid.
👀 கவனிக்க வேண்டியவை
Investors should monitor this as a strategic move to future-proof Rain's product portfolio for the EV battery supply chain. While immediate financial impact is limited, successful R&D could lead to high-margin specialty chemical opportunities by 2030.
Rainbow Children's Medicare Q3 FY26 Revenue Up 21% YoY; OP Consultations Surge 18%
Rainbow Children's Medicare reported a robust 21.2% YoY growth in operating revenue for Q3 FY26, reaching ₹4,057 million. The company witnessed strong volume growth with out-patient consultations increasing by 18% and in-patient discharges by 9%. Expansion remains a key theme, with three new hospitals operationalized in Warangal, Guwahati, and Rajahmundry during the fiscal year. While EBITDA grew 14.3% to ₹1,313 million, overall occupancy moderated to 47.2% due to the significant addition of new capacity beds.
முக்கிய அம்சங்கள்
Operating Revenue increased 21.2% YoY to ₹4,057 million in Q3 FY26.EBITDA stood at ₹1,313 million, up 14.3% YoY, with a margin of 32.4%.Out-patient consultations grew 18% YoY to 4,17,342; In-patient discharges rose 9% to 27,977.ARPOB (Average Revenue Per Occupied Bed) improved by 9% YoY to ₹58,362.Total capacity beds reached 2,285 following the addition of hospitals in Warangal, Guwahati, and Rajahmundry.
👀 கவனிக்க வேண்டியவை
Investors should monitor the occupancy levels and margin stabilization as the newly added hospitals move through their gestation periods. The strong growth in OP consultations and ARPOB suggests healthy underlying demand for specialized pediatric services.
Rainbow Children’s Q3 Revenue Up 11.9% YoY to ₹445 Cr; Focus Shifts to Execution
Rainbow Children’s Medicare reported a steady Q3 FY26 with revenue growing 11.9% YoY to ₹4,454 Mn and PAT increasing 7.2% to ₹739 Mn. While operational capacity expanded by 18% to 2,285 beds, occupancy rates dipped to 47.19% from 53.20% YoY due to the rapid addition of new units in Rajahmundry and Bengaluru. The company has largely completed its current expansion cycle and is now focusing on operational excellence and ramping up occupancy in new facilities. A strong cash position of ₹5,792 Mn supports future growth and ongoing projects in Gurugram and Pune without external debt.
முக்கிய அம்சங்கள்
Revenue grew 11.9% YoY to ₹4,454 Mn, while EBITDA margins remained healthy at 33.0%.Operational beds increased by 15% to 1,758, though occupancy fell 601 bps to 47.19% due to new capacity additions.ARPOB (Average Revenue Per Occupied Bed) improved by 9% YoY to ₹58,362.Commissioned two new hospitals in Rajahmundry (100 beds) and Electronic City, Bengaluru (90 beds).Maintains a robust cash and investment balance of ₹5,792 Mn as of December 31, 2025.
👀 கவனிக்க வேண்டியவை
Investors should monitor the occupancy ramp-up in newly commissioned units, as the shift from expansion to execution is expected to drive margin improvement. The company's ability to fund large-scale expansions in NCR and Pune through internal accruals remains a significant long-term positive.
Rainbow Children's Medicare Q3 Standalone PAT at ₹658.2 Mn, Revenue Up 3.4% YoY
Rainbow Children's Medicare reported a standalone revenue of ₹3,943.52 million for Q3 FY26, a 3.4% increase over ₹3,815.65 million in Q3 FY25. Standalone Profit After Tax (PAT) declined slightly by 1.7% YoY to ₹658.24 million, down from ₹669.75 million. Sequentially, the performance was lower than Q2 FY26, where revenue was ₹4,084.96 million and PAT was ₹731.67 million. The board also confirmed the appointment of Mr. Abrarali Dalal as CEO starting January 2026.
முக்கிய அம்சங்கள்
Standalone Revenue from operations grew 3.35% YoY to ₹3,943.52 millionStandalone Profit After Tax (PAT) decreased by 1.7% YoY to ₹658.24 millionTotal expenses rose to ₹3,166.74 million from ₹3,023.00 million in the previous year's quarterBasic EPS for the quarter stood at ₹6.48 compared to ₹6.60 in Q3 FY25Mr. Abrarali Dalal officially took charge as the Chief Executive Officer (CEO) on January 20, 2026
👀 கவனிக்க வேண்டியவை
The results indicate a period of consolidation with flat YoY profit growth and a sequential dip in margins. Investors should monitor the new CEO's impact on operational efficiency and the company's expansion strategy in the specialized pediatric healthcare market.
Bohra Industries: Mark AB Capital Becomes Promoter; Krishna Agarwal Reclassified to Public
Bohra Industries has announced a formal change in its promoter structure following the completion of an open offer by Mark AB Capital Private Limited. Krishna Agarwal, holding 10,98,239 shares (4.73% stake), has been reclassified from the 'Promoter' category to 'Public' category. Mark AB Capital is now officially recognized as the new promoter of the company. This transition follows the open offer completed on August 13, 2025, and adheres to SEBI's regulatory requirements for reclassification.
முக்கிய அம்சங்கள்
Mark AB Capital Private Limited is now the official Promoter of Bohra Industries following an Open Offer.Krishna Agarwal reclassified to Public category with a 4.73% stake (10,98,239 shares).The reclassification is effective immediately as per SEBI Regulation 31A(10).The outgoing promoter will have no board representation or KMP roles for at least three years.Company confirms compliance with Minimum Public Shareholding (MPS) requirements.
👀 கவனிக்க வேண்டியவை
Investors should monitor the new promoter's strategic plans and any potential changes in the company's operational management. The formalization of this leadership shift may lead to new growth initiatives or structural changes.
Rainbow Children's Medicare Launches 90-Bed Hospital in Bengaluru; Total Capacity at 2,375 Beds
Rainbow Children’s Medicare Limited (RCML) has inaugurated a new 90-bed spoke hospital in Electronic City, Bengaluru, increasing its total capacity to approximately 2,375 beds. The project, costing approximately ₹55 crore, was funded entirely through internal accruals, demonstrating strong cash flow management. This facility marks the company's fifth hospital in Bengaluru and will operate under the hub-and-spoke model linked to the Marathahalli hub. This expansion targets a high-growth corridor with a young population, enhancing the company's footprint in a key focus market.
முக்கிய அம்சங்கள்
New 90-bed spoke hospital launched in Electronic City, Bengaluru, increasing total capacity to ~2,375 beds.Total project investment of approximately ₹55 crore financed through internal accruals.Strengthens the hub-and-spoke model in Bengaluru, serving as a spoke to the Marathahalli hub.Company occupancy stood at 46.3% in Q2 FY 2025-26 prior to this addition.The facility offers comprehensive pediatric and perinatal services, including neonatal and pediatric intensive care.
👀 கவனிக்க வேண்டியவை
The expansion is a positive indicator of the company's growth strategy and ability to scale using internal funds. Investors should monitor the occupancy ramp-up at the new facility to assess its impact on future earnings.
Cerebra Integrated Receives E-Auction Sale Notice from Canara Bank under SARFAESI Act
Cerebra Integrated Technologies Limited has received an e-auction sale notice from Canara Bank, a secured lender, on January 23, 2026. This action, taken under Section 13(4) of the SARFAESI Act, 2002, follows a previous disclosure regarding debt issues dated July 15, 2025. The notice indicates that the bank is proceeding with the sale of secured assets to recover outstanding dues. This development highlights severe financial distress and the risk of asset liquidation for the company.
முக்கிய அம்சங்கள்
Received e-auction sale notice from Canara Bank on January 23, 2026Action initiated under Section 13(4) of the SARFAESI Act for recovery of secured debtsFollow-up to a previous regulatory intimation made on July 15, 2025Indicates a failure to resolve defaults with the secured lender leading to asset enforcement
👀 கவனிக்க வேண்டியவை
Investors should exercise extreme caution as the company faces asset seizure and liquidation by lenders. The enforcement of the SARFAESI Act suggests a high risk of insolvency or significant operational disruption.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
